FOS and neoplasm: These data demonstrate that constitutive AREG‐induced EGFR activation accelerates tumorigenesis in H2‐c‐fosLTR mice via enhanced tumor cell proliferation and survival resulting from increased pRSK2/pCREB/c‐Fos signaling.